Alzheimer’s patients ‘realistic’ but hopeful with approval of new drug
Jay Reinstein was diagnosed at age 57 with younger-onset Alzheimer's disease more than two years ago. After 25 years in local government, most recently serving as the assistant city manager in Fayetteville, NC, he began
Controversial New Alzheimer’s Drug: Why Some Patients Say Yes
By Kathleen Doheny July 7, 2021 -- Rolfe Johnson is a glass-half-full kind of guy, but also a realist. As a longtime attorney in Houston, only recently retired, he specialized in taking companies public, so
New Alzheimer’s Drug Aducanumab Stirs Controversy and Hope
Months before the US Food and Drug Administration (FDA) approved aducanumab (Aduhelm), the first medication thought to modify the progression of Alzheimer's disease, on June 7, Jay Reinstein had already made the decision to try it.
You’re Not Alone: Alzheimer’s Support Groups Can Help
Building a strong support network is one of the most important steps caregivers and individuals living with Alzheimer’s or dementia can take following a diagnosis. Support groups—whether in person, online or over the phone—can provide education,
Jim Butler participating in a Clinical Trial
Jim Butler is receiving his monthly 45-minute infusion of drugs. What kind of drugs? He doesn’t know. Nor do the nurses administering them. Could be an experimental medicine that will help his brain fight Alzheimer’s
ELIZABETH PLAYS FLAG FOOTBALL FOR THE FIRST TIME TO HONOR HER FATHER
Two years ago, Elizabeth Reinstein was a normal college student at East Carolina University, worried about finals and finishing her senior year. But when she graduated, her whole life changed. Her father, Jay, who she